Seed Funded World First Blood Biomarker for MS Types
Managing member of the International Progressive MS Alliance
zeposia on PBS
01 March, 2021

The Australian Government has announced the listing of ozanimod (Zeposia) for the treatment of relapsing remitting MS on the Pharmaceutical Benefits Scheme.

Image of Facebook
18 February, 2021

As a result of Facebook’s Australian news restrictions, MS Research Australia and MS Australia Facebook pages have been shut down.

Gift in Will to MS Research Australia - Image of Pearl
16 February, 2021

By leaving a gift in her Will to MS Research Australia, Pearl is changing the world for people with MS. Read more to find out how you can leave a gift.

The Australian MS Longitudinal Study

The Australian MS Longitudinal Study (AMSLS) is a long-term, survey-based, tracking study collecting data of practical use for improving the lives of Australians living with MS.

MS Research Australia Clinical Trials Network

The MS Research Australia Clinical Trials Network connects trial sponsors and clinical research organisations with potential trial sites, health professionals and people with MS in Australia and New Zealand.

Vitamin D MS Prevention Trial - PrevANZ

The vitamin D MS Prevention Trial is a clinical trial that will test whether vitamin D supplementation can prevent MS in those at risk of developing the disease.

MS Research Australia Brain Bank

The MS Research Australia Brain Bank coordinates the collection, storage and distribution of neurological tissue from people with MS for use in research.

Associate Professor Anthony Don
The Centenary Institute and the University of Sydney, NSW



Dr Marzena Pedrini
Murdoch University, WA



Dr Charles Malpas
University of Melbourne, VIC



Associate Professor Brad Sutherland
University of Tasmania, TAS




Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search